Insider · CIK 0001713722
Dennis Leo Walsh
Files at DCPH (Deciphera Pharmaceuticals, Inc.). First filing May 12, 2023, latest May 12, 2023.
In brief
Dennis Leo Walsh files SEC Form 4 as director at DCPH (Deciphera Pharmaceuticals, Inc.). Since May 12, 2023, Dennis Leo Walsh has reported 1 open-market buy worth $152k and 0 open-market sells worth $0, the latest filed on May 12, 2023.
A track record needs three past buys with six months of prices behind them; Dennis Leo Walsh has 0, so none is measured yet.
The newest scored trade: bought $152k of DCPH on May 10, 2023, filed May 12, 2023, scored 34 (weak).
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 34Weak | DCPHbuy Deciphera Pharmaceuticals, Inc. | $152k 11,000 shares | - | - |
Transactions
Every row this insider has filed, 12 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 11, 2024 | DCPH Deciphera Pharmaceuticals, Inc. | UTender of shares Common Stock | -11,000 | - | - | 0 | Jun 11, 2024 |
| Jun 11, 2024 | DCPH Deciphera Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -52,000 | - | - | 0 | Jun 11, 2024 |
| Jun 11, 2024 | DCPH Deciphera Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -12,000 | - | - | 0 | Jun 11, 2024 |
| Jun 11, 2024 | DCPH Deciphera Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -9,570 | - | - | 0 | Jun 11, 2024 |
| Jun 11, 2024 | DCPH Deciphera Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -18,500 | - | - | 0 | Jun 11, 2024 |
| Jun 11, 2024 | DCPH Deciphera Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -3,269 | - | - | 0 | Jun 11, 2024 |
| Jun 11, 2024 | DCPH Deciphera Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -30,000 | - | - | 0 | Jun 11, 2024 |
| Jun 11, 2024 | DCPH Deciphera Pharmaceuticals, Inc. | DDisposition to issuer Stock Option (Right to Buy)derivative | -4,727 | - | - | 0 | Jun 11, 2024 |
| Jan 16, 2024 | DCPH Deciphera Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +4,727 | $10.58 | $50k | 4,727 | Jan 18, 2024 |
| Jun 21, 2023 | DCPH Deciphera Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +30,000 | $0.00 | $0 | 30,000 | Jun 23, 2023 |
| May 10, 2023 | DCPH Deciphera Pharmaceuticals, Inc. | POpen-market purchase Common Stock | +11,000 | $13.86 | $152k | 11,000 | May 12, 2023 |
| Jan 17, 2023 | DCPH Deciphera Pharmaceuticals, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +3,269 | $15.30 | $50k | 3,269 | Jan 19, 2023 |
Questions about Dennis Leo Walsh
Answered from the filings on this page, as of the latest one.
Is Dennis Leo Walsh buying or selling?
Not in the last 12 months. Dennis Leo Walsh's latest open-market trade on SEC Form 4 was bought $152k of DCPH on May 10, 2023.
How did Dennis Leo Walsh's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Dennis Leo Walsh has 0.
Where does Dennis Leo Walsh file Form 4?
Dennis Leo Walsh has filed Form 4 at DCPH (Deciphera Pharmaceuticals, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.